Question to the Department of Health and Social Care:

To ask Her Majesty's Government what plans they have to consult antimicrobial clinical experts or representative expert bodies on any proposals designed to achieve de-linkage in respect of drug development in the UK.

The Government is working with industry and experts to develop a health technology assessment led evaluation and reimbursement model that supports good antimicrobial stewardship. A reimbursement sub group of the Joint Government and Industry Antimicrobial Resistance Working Group is considering new reimbursement models.

New models are contingent on a positive outcome of a study commissioned to help us better understand the value of new antimicrobials. This study is being undertaken through the Department’s Policy Research Programme, supported by an expert advisory group and is expected to report in the summer of 2018.